Profounda Inc.

Orlando, FL Profounda, Inc.

UEI
NR1ZD3ETM3N6
CAGE
7K0V7
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
10501 S Orange Ave #124, Orlando, FL 32824, USA
Website
profounda.com
Founded
2013
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Profounda Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Miltefosine (impavido) Contract · 36C26025P0684 Veterans Integrated Service Network 20 $49,950
Impavido Contract · 36C26025P0535 Veterans Integrated Service Network 20 $99,900
Emergent impavido inpatient Contract · 36C26025P0490 Veterans Integrated Service Network 20 $49,950
Impavido pharmacy order Contract · 36C26025P0452 Veterans Integrated Service Network 20 $16,650
Emergency pharmacy buy impavido (miltefosine) 84 tablets 3 packages of 28 okcvamc pharmacy Contract · 36C25925P0299 Veterans Integrated Service Network 19 $49,950

About Profounda Inc.

Profounda Inc., a self-certified small disadvantaged business registered in SAM.gov since February 2016, is a corporate entity specializing in pharmaceutical manufacturing located in Orlando, Florida. The company is primarily focused on producing and distributing specialized medical products, with a particular emphasis on critical pharmaceutical interventions. Profounda Inc. operates as a for-profit organization and has established itself as an exclusive manufacturer and license holder of specific pharmaceutical products, most notably Impavido (miltefosine), which is used to treat rare and complex medical conditions.

The company has an extensive history of federal contract awards, exclusively with the Department of Veterans Affairs (VA) Veterans Health Administration across multiple Veterans Integrated Service Networks (VISNs), including VISN 8, 19, 20, 23, and 16. Profounda Inc. has consistently been awarded firm fixed-price purchase orders for the delivery of Impavido/Miltefosine, a medication used to treat leishmaniasis and other drug-resistant infections. These contracts, ranging from $16,650 to $299,700, are part of a larger $1,127,000 Blanket Purchase Agreement (BPA) that allows for pre-positioning of the medication at VA medical centers. None of the awards have been set aside, and they are typically procured under "Only One Responsible Source" authority, reflecting Profounda's unique position as the exclusive U.S. manufacturer of this critical pharmaceutical product. The contracts demonstrate the company's crucial role in providing emergency medical solutions to the VA healthcare system, ensuring veterans have expedited access to specialized medications.

SBA capabilities narrative

Profounda is a product-oriented, privately backed pharmaceutical company that aims to develop high quality specialty niche pharmaceutical products in both the branded and generic pharmaceutical markets.

Quick answers

What is Profounda Inc.'s UEI?

Profounda Inc.'s Unique Entity ID (UEI) in SAM.gov is NR1ZD3ETM3N6.

What is Profounda Inc.'s CAGE code?

Profounda Inc.'s CAGE code is 7K0V7.

What is Profounda Inc.'s primary NAICS code?

Profounda Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Profounda Inc. located?

Profounda Inc.'s physical address in SAM.gov is 10501 S Orange Ave #124, Orlando, FL 32824, USA.

Is Profounda Inc. registered in SAM.gov?

Yes. Profounda Inc.'s SAM.gov registration is active through March 3, 2027.

What is Profounda Inc.'s most recent federal award?

Profounda Inc.'s most recent federal contract award is Miltefosine (impavido) (36C26025P0684), from Veterans Integrated Service Network 20, on May 1, 2025.

On GovTribe

See Profounda Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors